FDA proposes guidance for developing drugs for disseminated coccidioidomycosis
Regulatory NewsJeff Craven
GuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsJeff CravenGuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)